Neurocrine Biosciences (NASDAQ: NBIX) is scheduled to reveal its financial results for the third quarter on Wednesday 30th October 2024. This disclosure will take place before market open, providing investors with significant information regarding the company's performance in the last three months period.
It is anticipated by financial experts on Wall Street that the business is set to announce an estimated $1.50 profit per share for the quarter. Additionally, the firm is expected to disclose a total revenue of $600.63 million for this period.
The experts on Wall Street have shared their predictions for how well the company will do this year. They think the total revenue will be around $2.33 billion. They also believe the company will reach about profit of $4.55 per share for the fiscal year.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $1.54. This notable figure was achieved due to the company's impressive total revenue of $498.8 million recorded during that specific period.
NBIX has scheduled a conference call on 30th October 2024 at 08:00 AM eastern time to discuss the third quarter financial results and other related information.
Throughout Monday's trading, Neurocrine Biosciences (NBIX) shares fluctuated between $115.81 and $117.95, with a trading volume of 676.20 thousand shares. The stock ended the regular trading session at $116.20, showing an increase of 0.10 percent.
